Literature DB >> 12173104

Update on the taxonomy and clinical aspects of the genus fusobacterium.

Diane M Citron1.   

Abstract

The genus Fusobacterium currently includes 13 species. Fusobacterium nucleatum, the most frequently encountered species in humans, is heterogeneous and currently includes 5 subspecies. A potentially new subspecies of F. nucleatum that is intrinsically quinolone-resistant and phylogenetically separate from the other 5 subspecies has been identified from dog and cat oral flora. Two subspecies have been described for Fusobacterium necrophorum, and a new species, Fusobacterium equinum, which is related to F. necrophorum, has been described from horse oral flora. Additional molecular studies have characterized Fusobacterium ulcerans as separate from the phenotypically similar Fusobacterium mortiferum and Fusobacterium varium. Fusobacterium sulci and Fusobacterium alocis have been reclassified as Eubacterium sulci and Filifactor alocis, respectively. Fusobacterium prausnitzii is phylogenetically related to the Eubacterium-like organisms and will likely be reclassified in the future. The status of the remaining species is unchanged.

Entities:  

Mesh:

Year:  2002        PMID: 12173104     DOI: 10.1086/341916

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Pyogenic liver abscess caused by Fusobacterium in a 21-year-old immunocompetent male.

Authors:  Zohair Ahmed; Saurabh K Bansal; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Thyroid abscess due to a mixed anaerobic infection with Fusobacterium mortiferum.

Authors:  Nikolaos P Stavreas; Constantina D Amanatidou; Emmanuel G Hatzimanolis; Ioannis Legakis; George Naoum; Elli Lakka-Papadodima; George Georgoulias; Panagiota Morfou; Sotirios Tsiodras
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Filifactor alocis--a new emerging periodontal pathogen.

Authors:  A Wilson Aruni; Arunima Mishra; Yuetan Dou; Ozioma Chioma; Brittany N Hamilton; Hansel M Fletcher
Journal:  Microbes Infect       Date:  2015-04-02       Impact factor: 2.700

4.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 5.  Clindamycin-resistant Fusobacterium varium bacteremia and decubitus ulcer infection.

Authors:  M C Legaria; G Lumelsky; V Rodriguez; S Rosetti
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Adherence to streptococci facilitates Fusobacterium nucleatum integration into an oral microbial community.

Authors:  Xuesong He; Wei Hu; Christopher W Kaplan; Lihong Guo; Wenyuan Shi; Renate Lux
Journal:  Microb Ecol       Date:  2011-12-28       Impact factor: 4.552

7.  Vaginal bacterial community composition and concentrations of estradiol at the time of artificial insemination in Brangus heifers.

Authors:  Riley D Messman; Zully E Contreras-Correa; Henry A Paz; George Perry; Caleb O Lemley
Journal:  J Anim Sci       Date:  2020-06-01       Impact factor: 3.159

8.  Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.

Authors:  Poonam Dharmani; Jaclyn Strauss; Christian Ambrose; Emma Allen-Vercoe; Kris Chadee
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

9.  Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model.

Authors:  Rajendra P Settem; Ahmed Taher El-Hassan; Kiyonobu Honma; Graham P Stafford; Ashu Sharma
Journal:  Infect Immun       Date:  2012-04-30       Impact factor: 3.441

10.  Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.

Authors:  L Flanagan; J Schmid; M Ebert; P Soucek; T Kunicka; V Liska; J Bruha; P Neary; N Dezeeuw; M Tommasino; M Jenab; J H M Prehn; D J Hughes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.